All lobbying filings
INNOVATIVE FEDERAL STRATEGIES, LLC
Lobbying for X-BIOTIX THERAPEUTICS, INC. · biotechnology company
Filing
4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
Massachusetts
Government bodies contacted
1
Lobbying activity
1
H.R.5304/S.2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Title II, all provisions related to Antimicrobial Resistance.